The applications of pharmacogenetics to prescribing: what is currently practicable? (original) (raw)

On the use of pharmacogenetics in cancer treatment and clinical trials

Elisa Giovannetti

European journal of cancer (Oxford, England : 1990), 2014

View PDFchevron_right

Genetic Testing in Cancer Therapeutics

Robert Diasio

Clinical Cancer Research, 2006

View PDFchevron_right

Pharmacogenetic Application in Personalized Cancer Treatment

Ahmad Utomo

View PDFchevron_right

The basic principals of pharmacogenetics testing in cancer treatment

Viktorija Dragojević-simić

Hospital Pharmacology - International Multidisciplinary Journal

View PDFchevron_right

Pharmacogenetic And Tumour Drugs

Elizabeta Topic

EJIFCC, 2005

View PDFchevron_right

Practical recommendations for pharmacogenomics-based prescription: 2010 ESF–UB Conference on Pharmacogenetics and Pharmacogenomics

Pierre Laurent-puig

Pharmacogenomics, 2011

View PDFchevron_right

Primer on medical genomics. Part XII: Pharmacogenomics--general principles with cancer as a model

Richard Weinshilboum

Mayo Clinic proceedings, 2004

View PDFchevron_right

Pharmacogenetics of Cancer and DNA Repair Enzymes

tahar van der straaten

diabetes

View PDFchevron_right

Role of pharmacogenomics in the therapy of cancer

Dr. Sridevi Pingali

Journal of Biochemistry and Biotechnology, 2018

View PDFchevron_right

“Pharmacogenetics of Cancer” - Cancer Drug Resistance special issue

Cancer Drug Resistance

Cancer Drug Resistance, 2020

View PDFchevron_right

An introduction to the pharmacogenomics of oncology drugs

Dr. Mohitosh Biswas

Aus Pharmacist, 2017

View PDFchevron_right

Pharmacogenetics in the Cancer Clinic: From Candidate Gene Studies to Next-Generation Sequencing

tahar van der straaten

Clinical Pharmacology & Therapeutics, 2014

View PDFchevron_right

Polymorphisms in Pharmacogenetics of Personalized Cancer Therapy

Yasemin baskın

Genetic Polymorphisms

View PDFchevron_right

Toward individualized treatment: prediction of anticancer drug disposition and toxicity with pharmacogenetics

William Figg

Anti-Cancer Drugs, 2007

View PDFchevron_right

PHARMACOGENETICS- CLINICAL PHARMACOLOGY

magendira mani vinayagam

View PDFchevron_right

Polymorphisms to Predict Outcome to the Tyrosine Kinase Inhibitors Gefitinib, Erlotinib, Sorafenib and Sunitinib

Elisa Giovannetti, Godefridus J Peters

Current Topics in Medicinal Chemistry, 2012

View PDFchevron_right

Cancer Pharmacogenetics: perspective on newly discovered and implemented predictive biomarkers

Giuseppe Toffoli

Pharmadvances

View PDFchevron_right

Pharmacogenetics for individualized cancer chemotherapy

Thomas Efferth

Pharmacology & Therapeutics, 2005

View PDFchevron_right

Pharmacogenetics as Personalized Medicine: Association Investigation of SOD2 rs4880, CYP2C19 rs4244285, and FCGR2A rs1801274 Polymorphisms in a Breast Cancer Population in Iraqi Women

wisam hoidy

Clinical Breast Cancer

View PDFchevron_right

False Positive? The Commercial and Clinical Development of Pharmacogenetics

Andrew Smart

IGBis, SATSU, University of Nottingham, 2006

View PDFchevron_right

Pharmacogenetics and pharmacogenomics as tools in cancer therapy

Miguel Martín

Drug Metabolism and Personalized Therapy, 2016

View PDFchevron_right

Genetics as a Tool in Oncology Daily Practice

Francisco Javier Ochoa Carrillo

Gaceta Mexicana de Oncolog�a

View PDFchevron_right

Pharmacogenetics and pharmacogenomics: role of mutational analysis in anti-cancer targeted therapy

Raffaele Palmirotta

The Pharmacogenomics Journal, 2012

View PDFchevron_right

Pharmacogenetic application in drug development and clinical trials

Felix de la Iglesia, M. Bleavins

Drug metabolism and disposition: the biological fate of chemicals, 2001

View PDFchevron_right

Role of Pharmacogenetics as Predictive Biomarkers of Response and/or Toxicity in the Treatment of Colorectal Cancer

Shriya Bhushan

Clinical Colorectal Cancer, 2008

View PDFchevron_right

Challenges in constructing genetic instruments for pharmacologic therapies

Alberico Catapano

arXiv (Cornell University), 2020

View PDFchevron_right

Recommendations from the EGAPP Working Group: can testing of tumor tissue for mutations in EGFR pathway downstream effector genes in patients with metastatic colorectal cancer improve health outcomes by guiding decisions regarding anti-EGFR therapy?

Ben Djulbegovic

Genetics in Medicine, 2013

View PDFchevron_right

Cancer pharmacogenetics: polymorphisms, pathways and beyond

K. Robien

Nature Reviews Cancer, 2003

View PDFchevron_right

Pharmacogenetics: Genetic basis for rational drug therapy

Shubha Rani

Indian Journal of Pharmaceutical Sciences, 2007

View PDFchevron_right

Pharmacogenetics: a laboratory tool for optimizing therapeutic efficiency

Roland Valdes

Clinical chemistry, 1997

View PDFchevron_right

Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing

Stephen Lim

Expert Review of Molecular Diagnostics, 2012

View PDFchevron_right

23 Pharmacogenetics of Cancer and DNA Repair Enzymes

tahar van der straaten

2017

View PDFchevron_right

Cancer Pharmacogenomics and Pharmacoepidemiology: Setting a Research Agenda to Accelerate Translation

William Figg

JNCI Journal of the National Cancer Institute, 2010

View PDFchevron_right

The effect of genetic variability on drug response in conventional breast cancer treatment

Emilia Wiechec

European Journal of Pharmacology, 2009

View PDFchevron_right

Pharmacogenetics: implementing personalized medicine

Enrico Mini

Clinical Cases in Mineral and Bone Metabolism, 2009

View PDFchevron_right